The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome
暂无分享,去创建一个
Christopher P Crum | Judy E Garber | Michael J Callahan | J. Garber | D. Cramer | C. Feltmate | M. Muto | C. Crum | M. Callahan | J. Elvin | F. Medeiros | Yonghee Lee | Daniel W Cramer | Michael G Muto | Julia A Elvin | Colleen Feltmate | Fabiola Medeiros | Yonghee Lee
[1] R. Vang,et al. Immunohistochemical Staining for Ki-67 and p53 Helps Distinguish Endometrial Arias-Stella Reaction from High-Grade Carcinoma, Including Clear Cell Carcinoma , 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[2] S. Navani,et al. Tumors of the Fimbriated End of the Fallopian Tube: A Clinicopathologic Analysis of 20 Cases, Including Nine Carcinomas , 1997, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[3] R. Demopoulos,et al. Clues to the Pathogenesis of Fallopian Tube Carcinoma: A Morphological and Immunohistochemical Case Control Study , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[4] P. Kenemans,et al. Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause. , 2004, American journal of obstetrics and gynecology.
[5] S. Silverberg,et al. Mucosal Epithelial Proliferation of the Fallopian Tube: Prevalence, Clinical Associations, and Optimal Strategy for Histopathologic Assessment , 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[6] Rochelle L. Garcia,et al. Pathologic findings in prophylactic oophorectomy specimens in high-risk women. , 2002, Gynecologic oncology.
[7] Rochelle L. Garcia,et al. Unexpected Gynecologic Neoplasms in Patients With Proven or Suspected BRCA-1 or -2 Mutations: Implications for Gross Examination, Cytology, and Clinical Follow-up , 2002, The American journal of surgical pathology.
[8] P. Bannatyne,et al. Early adenocarcinoma of the fallopian tubes. A case for multifocal tumorigenesis. , 1981, Diagnostic gynecology and obstetrics.
[9] P. V. van Diest,et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer , 2001, The Journal of pathology.
[10] J. Niloff,et al. Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] T. Colgan. Challenges in the Early Diagnosis and Staging of Fallopian-Tube Carcinomas Associated with BRCA Mutations , 2003, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[12] B. Rosen,et al. Occult Carcinoma in Prophylactic Oophorectomy Specimens: Prevalence and Association With BRCA Germline Mutation Status , 2001, The American journal of surgical pathology.
[13] Rochelle L. Garcia,et al. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. , 2001, Gynecologic oncology.
[14] I. Shih,et al. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. , 2004, The American journal of pathology.
[15] S. Silverberg,et al. Mucosal Epithelial Proliferation of the Fallopian Tube: A Particular Association with Ovarian Serous Tumor of Low Malignant Potential? , 1995, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[16] M. Beattie,et al. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.